SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is experiencing significant volatility driven by renewed tariff threats against European allies, tied to geopolitical tensions over Greenland, sparking widespread market apprehension. The community is sharply divided between those anticipating a major pullback and those expecting a rapid "buy the dip" recovery, citing the market's historical resilience to such headlines. This situation unfolds as participants also eye a potential Supreme Court ruling on tariffs, which could further influence market direction.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is drawing considerable attention following its recent acquisition of VLX-1005, expanding its pipeline beyond a single asset, alongside ongoing progress for its flagship tecarfarin toward Phase 3 trials and manufacturing readiness. The community is actively debating its ultra-low float and the potential for tecarfarin to revolutionize anticoagulation therapy, with some analysts issuing high price targets. This discussion is set against concerns over past offerings and potential dilution, highlighting a polarized but active market interest in the microcap biotech.

KiboShib (KIBSHI) is the first AI-generated meme coin. On December 8th 2022, AI was tasked with creating a meme coin. It all started as a joke, but the idea which was proposed by the AI is so powerful that nobody could resist! The AI even suggested a logo design which later has been fed to the AI image generator. The age of AI is upon us, and KiboShib stands for exploring the capabilities of AI with a hopeful outlook.

KiboShib

KIBSHI CRYPTO is trending as the community rallies around its unique narrative as the first AI-generated meme coin, created by ChatGPT in 2022. This narrative, combined with growing AI hype, fuels discussions about its potential for substantial gains, with many comparing it to the early explosive runs of $DOGE and $SHIB. Investors are actively discussing its low market capitalization and positioning for what they anticipate could be a significant opportunity in the upcoming altcoin cycle.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending amid high anticipation for Supreme Court rulings on tariffs and escalating market debate over political influence on Federal Reserve policy. Community discussions are sharply divided, with some foreseeing disinflation and rate cuts supporting long-term bonds, while others remain concerned about geopolitical tensions and national debt sustaining higher yields. These intertwined factors are fueling significant uncertainty and varied trading strategies for the Treasury bond ETF.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending amid heightened geopolitical tensions sparked by recent tariff threats between the U.S. and European nations concerning Greenland, triggering a broad risk-off sentiment and significant liquidations in the crypto market. The community is actively debating whether this presents a buying opportunity or signals further declines, with many questioning Bitcoin's role as a safe haven asset amidst the escalating global uncertainty.

Oasis is a layer-one blockchain built to support confidential applications at scale. It’s home to Sapphire, the world’s first private EVM network, Oasis Privacy Layer, a cross-chain privacy solution for any EVM dApp, and Runtime Offchain Logic, a framework that brings trustworthy off-chain computing, onchain. Powered by its ROSE token, Oasis leverages a unique layered architecture and native rollup support, making it ideal for use cases in AI, DeFi, DAOs, gaming, and more.

Oasis Network

Oasis Network (ROSE) is trending as the community eagerly discusses its strong pivot into the AI narrative, with an anticipated rebrand to "Rose AI." Its foundational role in privacy-preserving AI, confidential computing, and Web3 developments is generating significant enthusiasm, positioning it as an undervalued asset with substantial growth potential.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

LABU is trending as the broader biotech sector experiences a significant rally, driven by accelerating advancements in AI-driven drug discovery and widespread anticipation of future Fed rate cuts. Community discussion highlights strong bullish sentiment, with many speculating about continued upward momentum and a rotation of capital into the sector.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares

LABD is trending as the S&P Biotech Select Industry Index (XBI) shows unusual resilience and continued bullish momentum, leading to significant frustration among investors anticipating a sector pullback. Despite widespread calls for a reversal based on technical divergences and broader economic concerns, XBI's strength, potentially fueled by M&A and market rotation, has left many "bag holding" this inverse ETF while keenly debating future entry opportunities.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is experiencing a surge in attention following significant global approvals for its Anktiva cancer therapy, notably for lung and bladder cancer, challenging established treatment paradigms. This development, combined with high short interest and the company's leadership actively promoting the science, has fueled community discussions around a potential short squeeze and a transformative shift in the biotech sector. Investors are keenly focused on the accelerated revenue prospects and broader market adoption of these innovative treatments.

JetBlue Airways Corp. engages in the provision of air transportation services. Its brands include jetBlue, jetBlue Vacations, Paisly, and TrueBlue. It operates through the following geographic segments: Domestic and Canada, Caribbean and Latin America, and Atlantic. The company was founded by David Gary Neeleman in August 1998 and is headquartered in Long Island City, NY.

Jetblue Airways Corp

JetBlue is trending with recent strong upward price action, fueled by strategic route expansions and the completion of its more efficient all-Airbus fleet transition. The community is actively discussing potential for a short squeeze and anticipating a significant move higher, particularly as lower fuel costs are expected to boost upcoming earnings.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zacks Research Has Negative Estimate for Revvity Q2 Earnings

Revvity Inc. (NYSE:RVTY - Free Report) - Research analysts at Zacks Research lowered their Q2 2026 earnings per share estimates for Revvity in a research note issued to investors on Thursday, January...

Sumitomo Mitsui Trust Group Inc. Trims Stake in Revvity Inc. $RVTY

Sumitomo Mitsui Trust Group Inc. cut its holdings in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 10.0% in the third quarter, according to the company in its most recent filing with the...

Revvity (NYSE:RVTY) Issues FY 2025 Earnings Guidance

Revvity (NYSE:RVTY) updated its FY 2025 earnings guidance. The company provided EPS guidance of 5.000- for the period, compared to the consensus estimate of 4.910. The company also issued revenue...

Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance

Revvity, Inc. (NYSE: RVTY), today announced that it will release its fourth quarter and full year 2025 financial results prior to market open on Monday, February 2, 2026. The Company will host a...

RVTY & Eli Lilly Partner to Expand Access to AI Drug Discovery Models

Revvity teams up with Eli Lilly to bring TuneLab AI models to Signals Xynthetica, aiming to unlock secure, federated drug discovery at scale.

Revvity Inc. $RVTY Shares Purchased by SG Americas Securities LLC

SG Americas Securities LLC raised its stake in Revvity Inc. (NYSE:RVTY - Free Report) by 531.8% in the third quarter, according to the company in its most recent disclosure with the Securities...

Allspring Global Investments Holdings LLC Has $70.79 Million Stock Holdings in Revvity Inc. $RVTY

Allspring Global Investments Holdings LLC lifted its position in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 14,741.7% in the third quarter, according to its most recent disclosure with the...

Revvity Inc. (NYSE:RVTY) Given Average Recommendation of "Hold" by Brokerages

Revvity Inc. (NYSE:RVTY - Get Free Report) has received an average recommendation of "Hold" from the fourteen brokerages that are currently covering the firm, Marketbeat Ratings reports. One research...

Revvity Advances AI-Driven Scientific Discovery With Signals Xynthetica

RVTY unveils Signals Xynthetica, an AI-augmented design platform that links predictive models with real lab data to speed discovery.

Revvity Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials Discovery

Revvity, Inc. (NYSE: RVTY) today announced the introduction of its forthcoming Signals Xynthetica Models-as-a Service (MaaS) AI offering within the Revvity Signals platform. The Signals Xynthetica...

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The firm operates through the following segments: Life Sciences and Diagnostics. The Life Sciences segment delivers innovative solutions to optimize workflows, boost productivity, and accelerate drug discovery and development. The Diagnostics segment provides instruments, reagents, assay platforms, and software to healthcare and research professionals, with a focus on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics to enhance patient outcomes. Revvity was founded on April 19, 1937 and is headquartered in Waltham, MA.

RVTY
Revvity Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RVTY News

RVTYRevvity Inc.